Table 2 2-Way ANOVAs assessing (A) the interaction between obesity and co-morbid conditions on coronary dilations and (B) the interaction between obesity and commonly prescribed medications on coronary dilations

Diabetes

0.043

0.836

Hypertension

0.587

0.447

Coronary artery disease

1.714

0.195

Hypercholesterolemia

3.634

0.061

Coronary artery bypass grafting

0.023

0.880

Aortic valve replacement

0.033

0.856

B

Interactions with obesity

F test

P value

ACE - Inhibitor

7.469

0.008

Angiotensin receptor blocker

3.801

0.056

Aspirin

0.081

0.777

Statin

3.923

0.052

Insulin

2.196

0.144

Oral anti-diabetic drug

0.186

0.668

Beta blocker

7.581

0.008

Diuretic

1.513

0.224

Calcium channel blocker

0.904

0.345

H+ blocker

0.449

0.505

Nitrate

0.864

0.356